COV2008

This study is investigating the safety and efficacy of the Johnson & Johnson Adv.26 booster vaccine in healthy adults who have previously received the Pfizer COVID-19 vaccine. This study is currently enrolling participants.

REGN COV-2069

This study is assessing antibodies for the prevention of SARS CoV-2 infection of asymptomatic healthy adults.

COV1001

This study is assessing two different dosages of an investigational COVID-19 vaccine in healthy adults. This trial completed enrollment in August 2020 and is ongoing.

Ascent – IPCAVD012/HVTN118

This study is evaluating different vaccine regimens using experimental HIV vaccines in healthy HIV-negative adults. The study finished enrollment in September 2017 and is ongoing.

Z002

This study assessed two different dosages of an investigational Zika Virus vaccine in healthy adults. The study closed enrollment in September 2018. Data analysis is underway.

IPCAVD010

This study assessed different vaccine schedules using two experimental HIV vaccines in healthy HIV-negative adults. The study started in March 2016 and was completed in January 2019.

Z001

This study evaluated different vaccine schedules using an investigational Zika Virus vaccine in healthy adults. The study started in October 2016 and was completed in June 2018.

T001

This study assessed different dosages of a monoclonal antibody in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.

T002

This study evaluated different dosages of a monoclonal antibody given in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.

T003

This study is assessing the use of an infusion of three antibodies as an alternative treatment for people living with HIV.